IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $370,000 | -31.9% | 11,700 | 0.0% | 0.01% | -44.0% |
Q4 2020 | $543,000 | -6.9% | 11,700 | -33.9% | 0.02% | -16.7% |
Q3 2020 | $583,000 | +15.4% | 17,700 | -3.8% | 0.03% | +7.1% |
Q2 2020 | $505,000 | -74.7% | 18,400 | -72.4% | 0.03% | -80.3% |
Q1 2020 | $1,994,000 | -58.4% | 66,600 | -77.0% | 0.14% | -47.4% |
Q4 2019 | $4,792,000 | +52.7% | 289,500 | +67.9% | 0.27% | +42.1% |
Q3 2019 | $3,138,000 | – | 172,400 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |